HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 44 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $4,000 | -81.8% | 12,049 | -62.3% | 0.00% | -50.0% |
Q4 2019 | $22,000 | -4.3% | 31,991 | -8.7% | 0.00% | 0.0% |
Q3 2019 | $23,000 | -55.8% | 35,037 | +12.6% | 0.00% | -33.3% |
Q2 2019 | $52,000 | -36.6% | 31,122 | -3.3% | 0.00% | -25.0% |
Q4 2018 | $82,000 | -61.9% | 32,191 | -24.5% | 0.00% | -69.2% |
Q3 2018 | $215,000 | -24.3% | 42,664 | -45.6% | 0.01% | -13.3% |
Q1 2018 | $284,000 | +165.4% | 78,360 | +24.0% | 0.02% | +200.0% |
Q3 2017 | $107,000 | – | 63,172 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 5,790,269 | $3,848,000 | 3.74% |
PERKINS CAPITAL MANAGEMENT INC | 2,353,153 | $1,564,000 | 1.35% |
Diametric Capital, LP | 269,822 | $179,000 | 0.15% |
Nantahala Capital Management | 5,000,000 | $3,323,000 | 0.12% |
Sio Capital Management, LLC | 300,000 | $199,000 | 0.06% |
Cowen Prime Services LLC | 100,000 | $66,000 | 0.03% |
Fondren Management LP | 40,375 | $27,000 | 0.02% |
Kalos Management, Inc. | 66,900 | $46,000 | 0.02% |
Alyeska Investment Group, L.P. | 1,387,665 | $922,000 | 0.01% |
Hayden Royal, LLC | 12,000 | $8,000 | 0.01% |